Literature DB >> 17362969

Leptin deficiency suppresses progression of atherosclerosis in apoE-deficient mice.

Tsuyoshi Chiba1, Shohei Shinozaki2, Toru Nakazawa2, Akio Kawakami2, Masumi Ai2, Eiji Kaneko2, Masanobu Kitagawa3, Kazuo Kondo4, Alan Chait5, Kentaro Shimokado6.   

Abstract

Both experimental and epidemiological studies suggest that leptin is one of the molecules responsible for accelerated atherosclerosis in obese humans. To confirm the notion, we studied whether leptin accelerates atherosclerosis in apoE(-/-) mice. Leptin deficient hyperlipidemic mice (ob/ob;apoE(-/-) mice) developed significantly less atherosclerosis than apoE(-/-) mice, when fed an atherogenic diet for 16 weeks from 8 weeks of age. Histological analysis revealed that most of the atherosclerotic lesions in ob/ob;apoE(-/-) mice remained as fatty streaks, while those in apoE(-/-) mice were mainly fibrous plaques. The decrease in atherosclerosis was not due to changes in the serum levels of cholesterol, TNF-alpha, or adiponectin. Exogenous leptin significantly increased atherosclerotic areas in apoE(-/-) mice, even though it decreased food intake and body weight. Our findings support the notion that leptin accelerates atherosclerosis.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17362969     DOI: 10.1016/j.atherosclerosis.2007.01.040

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  31 in total

1.  Modulation of leptin levels by oxidized linoleic acid: a connection to atherosclerosis?

Authors:  Meera Penumetcha; Nadya Merchant; Sampath Parthasarathy
Journal:  J Med Food       Date:  2010-12-27       Impact factor: 2.786

Review 2.  Leptin and cardiovascular disease: response to therapeutic interventions.

Authors:  Kwang Kon Koh; Sang Min Park; Michael J Quon
Journal:  Circulation       Date:  2008-06-24       Impact factor: 29.690

Review 3.  Adiponectin, Leptin, and Fatty Acids in the Maintenance of Metabolic Homeostasis through Adipose Tissue Crosstalk.

Authors:  Jennifer H Stern; Joseph M Rutkowski; Philipp E Scherer
Journal:  Cell Metab       Date:  2016-05-10       Impact factor: 27.287

4.  Prospective, randomized, single-blind comparison of effects of 6 months' treatment with atorvastatin versus pravastatin on leptin and angiogenic factors in patients with coronary artery disease.

Authors:  Yuji Takahashi; Mamoru Satoh; Tsuyoshi Tabuchi; Motoyuki Nakamura
Journal:  Heart Vessels       Date:  2011-06-04       Impact factor: 2.037

5.  Emerging role of adipokines as mediators in atherosclerosis.

Authors:  Hanrui Zhang; Jian Cui; Cuihua Zhang
Journal:  World J Cardiol       Date:  2010-11-26

6.  Leptin treatment inhibits the progression of atherosclerosis by attenuating hypercholesterolemia in type 1 diabetic Ins2(+/Akita):apoE(-/-) mice.

Authors:  John Y Jun; Zhexi Ma; Rajkumar Pyla; Lakshman Segar
Journal:  Atherosclerosis       Date:  2012-10-12       Impact factor: 5.162

7.  Stat3β mitigates development of atherosclerosis in apolipoprotein E-deficient mice.

Authors:  Jihyun Lee; William M Baldwin; Chih-Yuan Lee; Stephen Desiderio
Journal:  J Mol Med (Berl)       Date:  2013-04-26       Impact factor: 4.599

8.  A murine model of obesity with accelerated atherosclerosis.

Authors:  Victoria L King; Nicholas W Hatch; Huei-Wei Chan; Marcielle C de Beer; Frederick C de Beer; Lisa R Tannock
Journal:  Obesity (Silver Spring)       Date:  2009-06-04       Impact factor: 5.002

9.  Mechanisms by which diabetes increases cardiovascular disease.

Authors:  Christian A Gleissner; Elena Galkina; Jerry L Nadler; Klaus Ley
Journal:  Drug Discov Today Dis Mech       Date:  2007

10.  Visceral adipose tissue inflammation accelerates atherosclerosis in apolipoprotein E-deficient mice.

Authors:  Miina K Ohman; Yuechun Shen; Chinyere I Obimba; Andrew P Wright; Mark Warnock; Daniel A Lawrence; Daniel T Eitzman
Journal:  Circulation       Date:  2008-01-22       Impact factor: 29.690

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.